Menu
Washingtoner
  • Home
  • Business
  • Construction
  • Technology
  • Arts
  • Health
  • Property
  • Software
  • Marketing
Washingtoner

First Choice Neurology Pioneering Neurologists Administer the New FDA-Approved Drug Kisunla
Washingtoner/10263199

Trending...
  • Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety
  • Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
  • Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
Kisunla FDA Approved for Alzheimers
JUPITER, Fla. - Washingtoner -- First Choice Neurology, the largest neurology group in the United States, is set to make medical history next week as Dr. Jennifer Buczyner and Dr. Jeff Gelblum are among the first physicians in the country to administer the newly FDA-approved drug Kisunla to patients. This groundbreaking development marks a significant milestone in neurological care, offering new hope to patients battling a range of neurological conditions.

Kisunla, by Eli Lilly represents a promising advancement in neurology, specifically targeting Alzheimer's disease and dementia. Kisunla is used to treat adults with early symptomatic Alzheimer's disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.

Dr. Jeff Gelblum, Neurologist in Aventura, Florida, has significant experience using anti-amyloid infusion therapy for his patients with mild cognitive impairment and mild Alzheimer's disease. He has many patients taking Leqembi with which was FDA approved in July 2023.

He is also looking forward to using Kisunla in his patients for the same conditions and differentiates the two products, accordingly: "The two drugs target the same endpoint, reduction of brain amyloid plaque which is a marker of Alzheimer's disease. Leqembi is given twice a month for a full 18 months. Kisunla is once a month and may be able to be stopped as soon as six months, based upon clearance of amyloid plaque on a follow up brain PET scan. Leqembi has a lower incidence of side effects of brain swelling and bleeding."

More on Washingtoner
  • Spokane River Flows Meet Level 2 Drought Response
  • California Family Launches Billboard to Reach "Pardon Czar" Alice Marie Johnson
  • Rent Like A Champion Acquires CollegeWeekends
  • Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
  • Seligson Law Launches New Website to Support Cannabis Businesses in California and New York

Gelblum notes, "that a patient who is unable to go for twice monthly infusions and eager to possibly conclude treatment in as soon as six months, who can also assume the greater safety risk, would be a good candidate for the new treatment."

Dr. Jennifer Buczyner, Neurologist in Jupiter, Florida said, "The approval of Kisunla offers another opportunity for patients with mild cognitive impairment or mild dementia and brings those with mild cognitive impairment to early medical attention. In studies, Kisunla slowed cognitive and functional decline by up to 35 percent compared to placebo at 18 months and reduced patients' risk of progressing to the next clinical stage of disease by up to 39 percent.  We at First Choice Neurology are very excited to offer anti-amyloid therapies to our South Florida communities."

The introduction of Kisunla underscores First Choice Neurology's commitment to pioneering treatments that transform the landscape of neurological care. As the first physicians in the United States to administer Kisunla, Dr. Gelblum and Dr. Buczyner exemplify the group's leadership in bringing cutting-edge therapies to patients.

More on Washingtoner
  • South Tacoma Groundwater Protection District Code Update Public Hearing on August 12
  • databahn Announces Subscription Access to Fortune 500 GenAI Deep Dive Sales Intelligence Reports
  • AI startup Congero offers instant websites with 24/7 updates - aiming to replace web agencies
  • WonderDays Launches the UK's First AI Experience Gift Finder – Gifting Just Got So Much Easier!
  • CelluHeal™ Launches Full Line of Advanced Wound Dressings for Online Purchase in the USA, Canada, and Beyond

About First Choice Neurology
First Choice Neurology is the largest neurology group in the United States with over 60 Care Centers in multiple Florida counties and services at more than 45 major hospitals. The group provides comprehensive neurological care for patients with a wide range of conditions including Alzheimer's disease, dementia, epilepsy, migraines, multiple sclerosis, Parkinson's disease, sleep disorders, strokes, traumatic brain injuries, and more. With a commitment to innovation and patient-centered care, First Choice Neurology continues to lead advancements in neurological treatments nationwide.

For more information about Kisunla and First Choice Neurology, visit fcneurology.com

Contact
First Choice Neurology
***@fcneurology.net


Source: First Choice Neurology

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • "The Pornified Generation": Dr. Chris Samuels Exposes the Toxic Alliance Between Bro Culture and Pornography That's Rewiring a Generation
  • Spokane: Suspect in custody after deliberately set fire causes damage to building housing the Downtown Police Precinct
  • Multi-Agency Response Controls Dual Fires in Spokane
  • MoVO Media Marketing Expands CRE Marketing Powerhouse with Addition of Fly Jamerson
  • The Modern Insurance Store Expands Medicare Help Services for Seniors in Cincinnati
  • Hire a Business Plan Writer: What to Expect and Why It's Worth It
  • Ironside HR Named Fastest-Growing Staffing Firm for Second Year
  • Inframark Continues to Build Its Community Management Capabilities and Multi-Disciplinary Presence in Arizona
  • ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
  • Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
  • $10 Million Allocated to Establish Crypto Treasury Focused on High Value Ethereum (ETH) & Bitcoin (BTC) as Long-Term Holdings for Cybersecurity Leader
  • Sing For Your Supper: A Night of Musical Comedy and Drag for a Great Cause
  • Arcadis welcomes transportation leader Greg Spotts to advance mobility in Seattle and California
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • $100 to $200 Million Equity Agreement with Top Digital Advisor Bitwise to Power Major Digital Asset Initiative for Bitcoin and Solana: OFA Group
  • New Collaboration Launches Corporate ESG Solution for Responsible Decommissioning and Transparent Reporting
  • SlickCashLoan Launches Free Loan Calculator to Help You Plan Monthly Payments
  • TikTok Star ArcadeFriends Attempts 24-Hour Claw Machine Marathon at Lucky Puppy Arcade in Las Vegas
  • Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
  • Annual Snapshot Estimate of Spokane County's Homeless Population Shows Overall Decrease for Second Year in a Row
_catLbl0 _catLbl1

Popular on Washingtoner

  • purelyIV Blog Named One of the Top 45 IV Therapy Blogs by Feedspot - 136
  • GMO Miner: Creating a simple, efficient and reliable new cloud mining experience - 133
  • Exciting News: Pivotal Health Solutions Acquires Revolutionary Portable Parallel Bars - 129
  • Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) - 109
  • West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care - 103
  • New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient - 101
  • New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives - 101
  • Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
  • DCAS College opens new Representative Office in Malaysian Capital Kuala Lumpur
  • Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI

Similar on Washingtoner

  • Pixel Studio Productions Launches Same-Day Headshots in Houston
  • Sumter Landing Dental Care Launches Summer Special on Full Mouth Reconstruction
  • CelluHeal™ Launches Full Line of Advanced Wound Dressings for Online Purchase in the USA, Canada, and Beyond
  • Dr. Harmon Completes Prestigious Zygomatic Implant Residency in Brazil
  • Josh & Heidi Share Upcoming "Spreading the Good BUZZ" Podcast Guests, Select Top Five Elopement Locations as Their Instagram Presence Grows Globally
  • Ironside HR Named Fastest-Growing Staffing Firm for Second Year
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
  • The Citizens Commission on Human Rights Annual Purple Heart Day Event will be Hosted at the Historic Fort Harrison
  • Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute